The Predictive Value of Serum ß-HCG Levels in The Detection of Ectopic Pregnancy Sixteen Days after Embryo Transfer: A Cross-Sectional Study.

Beta Subunit Chorionic Gonadotropin Ectopic Pregnancy Reproductive Techniques Assisted

Journal

International journal of fertility & sterility
ISSN: 2008-076X
Titre abrégé: Int J Fertil Steril
Pays: Iran
ID NLM: 101487941

Informations de publication

Date de publication:
01 Apr 2023
Historique:
received: 03 01 2022
medline: 15 5 2023
pubmed: 15 5 2023
entrez: 15 5 2023
Statut: epublish

Résumé

To detect the predictive value of beta human chorionic gonadotropin (β-hCG) levels 16 days post embryo transfer (ET) regarding detection of an ectopic pregnancy (EP) in assisted reproductive technology (ART) cycles. In this cross-sectional study, we reviewed the database of Royan Institute from January 2011 to December 2014 and from January 2017 to December 2019 retrospectively. All cases with positive β-hCG levels sixteen days after ET were screened (n=4149). The pregnancies with oocyte or embryo donation and the multiple pregnancies based on the first ultrasound were excluded. All eligible singleton pregnancies with documented serum β-hCG levels at Royan institute laboratory (n=765) were included and then classified according to the type of pregnancy: EP (n=189) or non-EP (n=576). The data of the treatment cycle was extracted from the patients' files. A receiver operating characteristic (ROC) curve was used to detect the predictive power of the first measurement of β-hCG level in distinguishing EP from ongoing pregnancy in the ART and intrauterine insemination (IUI) cycles separately. Sensitivity, specificity, area under the ROC curve and 95% confidence intervals (CI) were calculated for each of the estimates. The mean levels of β-hCG 16 days after ET were remarkably higher in the ongoing pregnancy group than the EP group (1592.35 ± 87 IU/L vs. 369.69 ± 50.61 IU/L, P<0.001). The β-hCG thresholds predictive of ongoing pregnancy were 278 IU/L as the most suitable cut-off to predict viable pregnancy with a sensitivity of 72.8%, a specificity of 67.5%, a positive predictive value of 77.8%, standard error of 0.02, and a confidence interval of 73.8- 81.7%. However, this relationship was not found in IUI cycles. Based on these findings, if β-hCG levels 16 days after ET are below 278 IU/l, close follow-up is recommended, until either the diagnosis of EP or miscarriage is established.

Sections du résumé

BACKGROUND BACKGROUND
To detect the predictive value of beta human chorionic gonadotropin (β-hCG) levels 16 days post embryo transfer (ET) regarding detection of an ectopic pregnancy (EP) in assisted reproductive technology (ART) cycles.
MATERIALS AND METHODS METHODS
In this cross-sectional study, we reviewed the database of Royan Institute from January 2011 to December 2014 and from January 2017 to December 2019 retrospectively. All cases with positive β-hCG levels sixteen days after ET were screened (n=4149). The pregnancies with oocyte or embryo donation and the multiple pregnancies based on the first ultrasound were excluded. All eligible singleton pregnancies with documented serum β-hCG levels at Royan institute laboratory (n=765) were included and then classified according to the type of pregnancy: EP (n=189) or non-EP (n=576). The data of the treatment cycle was extracted from the patients' files. A receiver operating characteristic (ROC) curve was used to detect the predictive power of the first measurement of β-hCG level in distinguishing EP from ongoing pregnancy in the ART and intrauterine insemination (IUI) cycles separately. Sensitivity, specificity, area under the ROC curve and 95% confidence intervals (CI) were calculated for each of the estimates.
RESULTS RESULTS
The mean levels of β-hCG 16 days after ET were remarkably higher in the ongoing pregnancy group than the EP group (1592.35 ± 87 IU/L vs. 369.69 ± 50.61 IU/L, P<0.001). The β-hCG thresholds predictive of ongoing pregnancy were 278 IU/L as the most suitable cut-off to predict viable pregnancy with a sensitivity of 72.8%, a specificity of 67.5%, a positive predictive value of 77.8%, standard error of 0.02, and a confidence interval of 73.8- 81.7%. However, this relationship was not found in IUI cycles.
CONCLUSION CONCLUSIONS
Based on these findings, if β-hCG levels 16 days after ET are below 278 IU/l, close follow-up is recommended, until either the diagnosis of EP or miscarriage is established.

Identifiants

pubmed: 37183844
doi: 10.22074/ijfs.2022.546087.1247
pmc: PMC10189163
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

181-186

Références

J Assist Reprod Genet. 2013 Nov;30(11):1459-63
pubmed: 24043384
J Assist Reprod Genet. 2009 Jun;26(6):347-54
pubmed: 19513822
Hum Reprod. 1999 Jun;14(6):1642-6
pubmed: 10357992
J Gynecol Obstet Hum Reprod. 2021 Nov;50(9):102169
pubmed: 34044136
Fertil Steril. 2011 May;95(6):1966-9
pubmed: 21377154
J Hum Reprod Sci. 2017 Apr-Jun;10(2):108-113
pubmed: 28904499
Hum Reprod. 2002 Jul;17(7):1901-5
pubmed: 12093858
Clin Exp Reprod Med. 2012 Mar;39(1):28-32
pubmed: 22563548
J Huazhong Univ Sci Technolog Med Sci. 2017 Jun;37(3):395-400
pubmed: 28585131
J Assist Reprod Genet. 1995 Oct;12(9):594-8
pubmed: 8580656
Obstet Gynecol. 2015 Jan;125(1):70-78
pubmed: 25560107
J Reprod Med. 2014 May-Jun;59(5-6):285-92
pubmed: 24937971
Reprod Biol Endocrinol. 2015 Apr 12;13:30
pubmed: 25884617
Fertil Steril. 2016 Jul;106(1):90-94
pubmed: 27001382
Fertil Steril. 2007 Jul;88(1):82-9
pubmed: 17307176
J Huazhong Univ Sci Technolog Med Sci. 2014 Feb;34(1):103-107
pubmed: 24496687
Fertil Steril. 1999 Aug;72(2):305-9
pubmed: 10439001

Auteurs

Seyedehhoura Hashemi (S)

Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.

Arezoo Arabipoor (A)

Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.

Solmaz Kohestani (S)

Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.

Zahra Zolfaghary (Z)

Reproductive Epidemiology Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.

Samira Vesali (S)

Reproductive Epidemiology Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.

Firouzeh Ghaffari (F)

Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran. Email:ghaffari@royaninstitute.org.

Classifications MeSH